Macquarie Group Limited 13D and 13G filings for Supernus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-01 4:35 pm Sale | 2024-09-30 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Macquarie Group Limited | 2,631,897 4.780% | -105,824 (-3.87%) | Filing |
| 2024-02-14 07:06 am Purchase | 2023-12-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Macquarie Group Limited | 2,737,721 5.010% | 2,737,721 (New Position) | Filing |